These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 16716414

  • 1. Antiviral therapy of chronic hepatitis B.
    Zoulim F.
    Antiviral Res; 2006 Sep; 71(2-3):206-15. PubMed ID: 16716414
    [Abstract] [Full Text] [Related]

  • 2. How to overcome antiviral-resistant hepatitis B virus?
    Song BC.
    Intervirology; 2010 Sep; 53(1):29-38. PubMed ID: 20068338
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Antiviral therapy of chronic hepatitis B: prevention of drug resistance.
    Fournier C, Zoulim F.
    Clin Liver Dis; 2007 Nov; 11(4):869-92, ix. PubMed ID: 17981233
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Chronic hepatitis B: who to treat and which choice of treatment?
    Di Marco V, Craxì A.
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):281-91. PubMed ID: 19344242
    [Abstract] [Full Text] [Related]

  • 8. Treatment of chronic hepatitis B and the implications of viral resistance to therapy.
    Mauss S, Wedemeyer H.
    Expert Rev Anti Infect Ther; 2008 Apr; 6(2):191-9. PubMed ID: 18380601
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antiviral drug resistance: clinical consequences and molecular aspects.
    Bartholomeusz A, Locarnini SA.
    Semin Liver Dis; 2006 May; 26(2):162-70. PubMed ID: 16673294
    [Abstract] [Full Text] [Related]

  • 11. [Future perspectives and strategies in managing resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].
    Bourlière M.
    Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S34-6. PubMed ID: 17075495
    [No Abstract] [Full Text] [Related]

  • 12. Entecavir for the long-term treatment of chronic hepatitis B.
    Gonzalez SA, Keeffe EB.
    Expert Rev Anti Infect Ther; 2009 Nov; 7(9):1053-62. PubMed ID: 19883325
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The clinical impact of early detection of the YMDD mutant on the outcomes of long-term lamivudine therapy in patients with chronic hepatitis B.
    Paik YH, Han KH, Hong SP, Lee HW, Lee KS, Kim SO, Shin JE, Ahn SH, Chon CY, Moon YM.
    Antivir Ther; 2006 Nov; 11(4):447-55. PubMed ID: 16856618
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Current therapy with nucleoside/nucleotide analogs for patients with chronic hepatitis B.
    Xu XW, Chen YG.
    Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):350-9. PubMed ID: 16911930
    [Abstract] [Full Text] [Related]

  • 20. Antiviral-resistant hepatitis B virus: can we prevent this monster from growing?
    Zoulim F, Buti M, Lok AS.
    J Viral Hepat; 2007 Nov; 14 Suppl 1():29-36. PubMed ID: 17958640
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.